Literature DB >> 10970349

Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.

V N Loparev1, T Argaw, P R Krause, M Takayama, D S Schmid.   

Abstract

A new method was developed to identify and differentiate varicella-zoster virus (VZV) wild-type strains from the attenuated varicella Oka vaccine strain. The PCR technique was used to amplify a VZV open reading frame (ORF) 62 region. A single specific amplicon of 268 bp was obtained from 71 VZV clinical isolates and several laboratory strains. Subsequent digestion of the VZV ORF 62 amplicons with SmaI enabled accurate strain differentiation (three SmaI sites were present in amplicons of vaccine strain VZV, compared with two enzyme cleavage sites for all other VZV strains tested). This method accurately differentiated the Oka vaccine strain from wild-type VZV strains circulating in countries representing all six populated continents. Moreover, the assay more reliably distinguished wild-type Japanese strains from the vaccine strain than did previously described methods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970349      PMCID: PMC87343     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction.

Authors:  M Yoshida; T Tamura; M Hiruma
Journal:  J Med Virol       Date:  1999-05       Impact factor: 2.327

Review 2.  Live attenuated varicella vaccine.

Authors:  A M Arvin; A A Gershon
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

3.  Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995.

Authors:  K Hawrami; I J Hart; F Pereira; S Argent; B Bannister; B Bovill; D Carrington; M Ogilvie; S Rawstorne; Y Tryhorn; J Breuer
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain).

Authors:  N Takayama; M Minamitani; M Takayama
Journal:  Acta Paediatr Jpn       Date:  1997-12

5.  Varicella vaccine.

Authors:  S A Plotkin
Journal:  Pediatrics       Date:  1996-02       Impact factor: 7.124

6.  A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.

Authors:  A A Gershon; S Steinberg; L Gelb; G Galasso; W Borkowsky; P LaRussa; A Ferrara
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

7.  Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.

Authors:  T Argaw; J I Cohen; M Klutch; K Lekstrom; T Yoshikawa; Y Asano; P R Krause
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.

Authors:  P LaRussa; S Steinberg; A Arvin; D Dwyer; M Burgess; M Menegus; K Rekrut; K Yamanishi; A Gershon
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis.

Authors:  C Mori; R Takahara; T Toriyama; T Nagai; M Takahashi; K Yamanishi
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Genome differences among varicella-zoster virus isolates.

Authors:  S E Straus; J Hay; H Smith; J Owens
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

View more
  39 in total

Review 1.  25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.

Authors:  M Takahashi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

3.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

5.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.

Authors:  Paul A Campsall; Nicholas H C Au; Julie S Prendiville; David P Speert; Rusung Tan; Eva E Thomas
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 7.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

8.  Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.

Authors:  Akinao Okamoto; Akihiro Abe; Masataka Okamoto; Tsukane Kobayashi; Tomohiko Terazawa; Yoko Inaguma; Masutaka Tokuda; Masamitsu Yanada; Satoko Morishima; Tadaharu Kanie; Yukiya Yamamoto; Motohiro Tsuzuki; Yoshiki Akatsuka; Shuichi Mizuta; Tetsushi Yoshikawa; Nobuhiko Emi
Journal:  Int J Hematol       Date:  2012-08-18       Impact factor: 2.490

9.  Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Authors:  Dana Perella; Chengbin Wang; Rachel Civen; Kendra Viner; Karen Kuguru; Irini Daskalaki; D Scott Schmid; Adriana S Lopez; Hung Fu Tseng; E Claire Newbern; Laurene Mascola; Stephanie R Bialek
Journal:  Pediatrics       Date:  2016-03-14       Impact factor: 7.124

10.  New variant of varicella-zoster virus.

Authors:  Graham A Tipples; Gwen M Stephens; Chris Sherlock; Margrit Bowler; Benny Hoy; Darrel Cook; Charles Grose
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.